UK MIDDAY BRIEFING: AstraZeneca Asks For Investor Patience
LONDON (Alliance News) - <strong>AstraZeneca</strong> Tuesday set out its defence against a GBP63 billion takeover offer from US rival Pfizer Inc, urging its investors to be patient because it is set to grow quickly after it invests in its pipeline and transforms the company over the next few Read More